Michael Mosticchio - Blue Owl Head Relations
| OBDC Stock | 15.22 0.12 0.79% |
Executive
Michael Mosticchio is Head Relations of Blue Owl Capital
| Address | 399 Park Avenue, New York, NY, United States, 10022 |
| Phone | 212-419-3000 |
| Web | https://www.blueowlcapitalcorporation.com |
Blue Owl Management Efficiency
The company has return on total asset (ROA) of 0.0559 % which means that it generated a profit of $0.0559 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1052 %, meaning that it created $0.1052 on every $100 dollars invested by stockholders. Blue Owl's management efficiency ratios could be used to measure how well Blue Owl manages its routine affairs as well as how well it operates its assets and liabilities. At present, Blue Owl's Return On Equity is projected to increase slightly based on the last few years of reporting. At present, Blue Owl's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.12, whereas Total Assets are forecasted to decline to about 9.7 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Qingmei Wang | HUTCHMED DRC | 61 | |
| Lara Zhao | 17 Education Technology | N/A | |
| Zhenping MBA | HUTCHMED DRC | 65 | |
| Kuanghao Zhang | 17 Education Technology | 36 | |
| April Dovholuk | Centessa Pharmaceuticals PLC | N/A | |
| Christine Gordon | RadNet Inc | 61 | |
| Lehua He | Four Seasons Education | N/A | |
| Harris Rotman | Centessa Pharmaceuticals PLC | N/A | |
| Patrick MD | Centessa Pharmaceuticals PLC | N/A | |
| Olivia Li | Four Seasons Education | N/A | |
| JD Esq | Centessa Pharmaceuticals PLC | N/A | |
| Marni Stein | Coursera | N/A | |
| Yiling Cui | HUTCHMED DRC | N/A | |
| Mustafa Furniturewala | Coursera | N/A | |
| Marcelo Modica | Coursera | N/A | |
| Kin MBA | HUTCHMED DRC | 47 | |
| MSc MD | Centessa Pharmaceuticals PLC | 66 | |
| David Ng | HUTCHMED DRC | N/A | |
| Hong Chen | HUTCHMED DRC | 54 | |
| Michael Murdock | RadNet Inc | 69 | |
| Selina Zhang | HUTCHMED DRC | N/A | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0559 |
Blue Owl Capital Leadership Team
Elected by the shareholders, the Blue Owl's board of directors comprises two types of representatives: Blue Owl inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Blue. The board's role is to monitor Blue Owl's management team and ensure that shareholders' interests are well served. Blue Owl's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Blue Owl's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Erik Bissonnette, Managing Director | ||
| CPA CPA, Executive President | ||
| Jean Joseph, Managing Director | ||
| Michael Mosticchio, Head Relations | ||
| Bryan CPA, Chief CoController | ||
| Dana Sclafani, Head Relations | ||
| Logan Nicholson, President | ||
| Shari Withem, CoTreasurer CoController | ||
| Karen Hager, Chief Officer | ||
| Craig Packer, CEO President | ||
| Dhruv Narain, Managing Director | ||
| Amy Ward, Managing Office | ||
| Scott Turco, Managing Director | ||
| Jonathan CPA, CFO COO | ||
| Alan CPA, Executive President |
Blue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Blue Owl a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0559 | ||||
| Profit Margin | 0.39 % | ||||
| Operating Margin | 0.76 % | ||||
| Current Valuation | 13.23 B | ||||
| Shares Outstanding | 390.22 M | ||||
| Shares Owned By Insiders | 0.12 % | ||||
| Shares Owned By Institutions | 41.49 % | ||||
| Number Of Shares Shorted | 4.11 M | ||||
| Price To Book | 0.99 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Blue Owl Capital is a strong investment it is important to analyze Blue Owl's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Blue Owl's future performance. For an informed investment choice regarding Blue Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Blue Owl Capital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Blue Owl. If investors know Blue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Blue Owl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.35) | Dividend Share 1.46 | Earnings Share 1.61 | Revenue Per Share 4.138 | Quarterly Revenue Growth 0.018 |
The market value of Blue Owl Capital is measured differently than its book value, which is the value of Blue that is recorded on the company's balance sheet. Investors also form their own opinion of Blue Owl's value that differs from its market value or its book value, called intrinsic value, which is Blue Owl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Blue Owl's market value can be influenced by many factors that don't directly affect Blue Owl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Blue Owl's value and its price as these two are different measures arrived at by different means. Investors typically determine if Blue Owl is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Blue Owl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.